Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

Until you have made your first substantial production cycle, you are still learning how to crawl.

Even if KBLB was capable of providing eggs for a thousand metric tons per year, don’t you think they would prefer a thousand tons of BAM-1/DS than eight hundred tons of mundane silk and 200 tons of BAM-1/DS.

Production costs will be about the same. Sales price for BAM-1/DS should be higher. Bigger markup = bigger profit.

KBLB may have done some useful work in developing disease resistant silkworms. But that can be done by other competitors. If it is a lucrative market, KBLB will have a lot of competition.

But let me ask you: What would you prefer? KBLB developing new and improved versions of DS, or developing mundane silkworms by crossing existing strains and breeding for disease resistance?